TY - JOUR
T1 - Diagnosis and management of adrenal tumors
AU - Sloan, David A.
AU - Schwartz, Richard W.
AU - McGrath, Patrick C.
AU - Kenady, Daniel E.
PY - 1996
Y1 - 1996
N2 - Tumors of the adrenal gland are not uncommon. Patients with these tumors usually demonstrate symptoms associated with the biochemical substance or hormone produced by the tumor. Tumors of the adrenal cortex, whether benign or malignant, are often associated with excess production of steroids, whereas tumors of the medulla are generally associated with overproduction of catecholamines. With the ubiquitous use of computed tomographic imaging, many asymptomatic adrenal lesions are discovered, presenting a management problem for the clinician. The algorithm for investigating so-called adrenal 'incidentalomas' in the current era of cost containment continues to evolve. This review addresses current trends in the clinical evaluation, biochemical testing, and nuclear and radiologic imaging in the diagnostic work-up of these neoplasms. The mainstay of treatment is still surgical extirpation, the only curative modality. However, advances have occurred in adjuvant therapies, perhaps best typified by the neoadjuvant use of 131I-methyl iodobenzylguanidine in the treatment of neuroblastoma.
AB - Tumors of the adrenal gland are not uncommon. Patients with these tumors usually demonstrate symptoms associated with the biochemical substance or hormone produced by the tumor. Tumors of the adrenal cortex, whether benign or malignant, are often associated with excess production of steroids, whereas tumors of the medulla are generally associated with overproduction of catecholamines. With the ubiquitous use of computed tomographic imaging, many asymptomatic adrenal lesions are discovered, presenting a management problem for the clinician. The algorithm for investigating so-called adrenal 'incidentalomas' in the current era of cost containment continues to evolve. This review addresses current trends in the clinical evaluation, biochemical testing, and nuclear and radiologic imaging in the diagnostic work-up of these neoplasms. The mainstay of treatment is still surgical extirpation, the only curative modality. However, advances have occurred in adjuvant therapies, perhaps best typified by the neoadjuvant use of 131I-methyl iodobenzylguanidine in the treatment of neuroblastoma.
UR - http://www.scopus.com/inward/record.url?scp=0029945582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029945582&partnerID=8YFLogxK
U2 - 10.1097/00001622-199601000-00006
DO - 10.1097/00001622-199601000-00006
M3 - Review article
C2 - 8868097
AN - SCOPUS:0029945582
SN - 1040-8746
VL - 8
SP - 30
EP - 36
JO - Current Opinion in Oncology
JF - Current Opinion in Oncology
IS - 1
ER -